ERBB2 and breast carcinoma: AFAP1-AS1 upregulation caused by H3K27ac modification enhances the translation of ERBB2 by binding to a mRNA decay factor AU-rich binding factor 1 (AUF1), which leads to trastuzumab resistance in breast cancer [128].